Sorry, you need to enable JavaScript to visit this website.
跳转到主要内容

我们的管理

Location Settings

Asia-Pacific

AU -  Sydney
AU -  Melbourne
AU -  Brisbane
CN -  Hong Kong
CN -  Shanghai
IN -  Bangalore
MY -  Kuala Lumpur
PH -  Metro Manila
KR -  Seoul
CN -  Taipei City
TH -  Bangkok
NZ -  New Zealand

North America

US -  San Francisco
US -  Boston

GLOBAL

English

CAREERS

SOLUTIONS

RESOURCES

ABOUT US

Location Settings

Asia-Pacific

AU -  Sydney
AU -  Melbourne
AU -  Brisbane
CN -  Hong Kong
CN -  Shanghai
IN -  Bangalore
MY -  Kuala Lumpur
PH -  Metro Manila
KR -  Seoul
CN -  Taipei City
TH -  Bangkok
NZ -  New Zealand

North America

US -  San Francisco
US -  Boston

GLOBAL

English

董事会

Anand Tharmaratnam

Anand Tharmaratnam

Chairman
Anand Tharmaratnam

Anand Tharmaratnam

Chairman

Anand brings over 20 years of experience in global drug development and the CRO industry. He was previously the president of Asia Pacific at IQVIA. Anand is a medical doctor by training and graduated from the University College London, UK and trained in the anaesthesia.

Photo of Joel Thickins

Joel Thickins

Board Member
Photo of Joel Thickins

Joel Thickins

Board Member

Joel is a Partner at TPG Capital and leads the firm’s investment program in the ANZ region as Head of Australia and New Zealand. Joel has previously served on the board of Inghams Group Limited and Accolade Wines Holding Australia Pty Limited.

Before joining TPG, Joel was a director at CPE Capital (formerly known as CHAMP Private Equity) where he was responsible for the company’s activities in the industrial, agricultural services and consumer markets.

Dr. Fred Cohen

Dr. Fred Cohen

博士——董事会成员
Dr. Fred Cohen

Dr. Fred Cohen

博士——董事会成员

Fred Cohen是TPG的高级顾问,也是TPG生物技术的合伙人和联合创始人。他曾在多家生物技术和制药机构的董事会任职,其中包括生物Biocryst(BCRX)、CareDx(CDNA)、[...],同时,他也是Sweetwater Spectrum(一家非盈利的自闭症支援组织)的联合创始人。

 Vincent Wong

Vincent Wong

Board Member
 Vincent Wong

Vincent Wong

Board Member

Vincent Wong is a Managing Director with TPG Capital and is based in Melbourne, where he works in TPG’s Australian team. Prior to joining TPG in 2011, Vincent served in the corporate advisory division at Goldman Sachs Australia. Vincent graduated from the University of Melbourne with BCommerce and BLaws (Honors).

 Lydia Cai

Lydia Cai

Board Member
 Lydia Cai

Lydia Cai

Board Member

Lydia Cai is a Managing Director with TPG Capital based in Beijing and leads TPG’s healthcare investments in the Greater China area. Prior to joining TPG in 2011, Lydia was an investment associate at HAO Capital, a China-focused early stage private equity fund focusing on growth-stage healthcare investments.

John Moller

John Moller

首席执行官
John Moller

John Moller

首席执行官

John于2014年1月加入Novotech,负责Novotech亚洲业务的发展。他原是IVF Australia and Queensland Fertility集团的常务董事,同时也是其母公司Virtus Health的董事会成员。John还是一名医生。

管理层

John Moller

John Moller

首席执行官
John Moller

John Moller

首席执行官

John于2014年1月加入Novotech,负责Novotech亚洲业务的发展。他原是IVF Australia and Queensland Fertility集团的常务董事,同时也是其母公司Virtus Health的董事会成员。John还是一名医生。

Michael stibilj

Michael stibilj

Chief Operating Officer
Michael stibilj

Michael stibilj

Chief Operating Officer

Michael has 25 years of experience in the CRO Industry. Prior to joining Novotech in 2017, Michael spent 15 years building and leading operations across Asia for Quintiles/IQVIA, and was senior advisor for TPG Capital.

Zidong

Zidong Zhang

Group Chief Finance Officer
Zidong

Zidong Zhang

Group Chief Finance Officer

Zidong Zhang is responsible for all aspects of financial management to support the growth of Novotech across Asia. Prior to joining Novotech, Dr. Zhang was CFO at Shanghai Henlius Biotech, Inc. a Hong Kong-listed global biopharmaceutical company based in Shanghai, where he built and managed the finance team and played an integral role in the company’s initial public offering in 2019. Prior to that, Dr. Zhang was an equity research analyst at UBS in New York, where he covered the United States large cap pharmaceutical and specialty pharmaceutical sector.

Barry Murphy

Barry Murphy

业务发展总监
Barry Murphy

Barry Murphy

业务发展总监

Barry于2014年7月加入Novotech,在其领导下,业务发展团队不断成长壮大。Barry就读于都柏林圣三一大学,毕业后成为一名药剂师。他在ICON开始其临床研究生涯,曾在都柏林和悉尼工作。

Andy Liu

Andy Liu

Head of China
Andy Liu

Andy Liu

Head of China

Andy worked at Covance, Inc., a global CRO, for more than 10 years in a number of executive positions. Most recently, he was General Manager of Covance's Central Laboratory Service, Asia Pacific, where he led a large multi-functional team of across multiple sites in APAC. Andy holds an MBA from the University of Chicago, an MS in Electrical Engineering from the Rose-Hulman Institute of Technology, and a BS in Electrical Engineering from Tsinghua University.

Veronica Holloway

Veronica Holloway

法务总监
Veronica Holloway

Veronica Holloway

法务总监

Veronica于2014年5月加入Novotech,负责Novotech的法律部门。加入Novotech之前,他曾在安永担任高级法律顾问,在Clayton Utz律师事务所担任高级律师,且在诺华制药澳大利亚公司担任法律总顾问(挂职)。Veronica拥有BA/LLB/LLM学位。

Angela Edwardson

Angela Edwardson

人力资源总监
Angela Edwardson

Angela Edwardson

人力资源总监

Angela于2015年11月加入Novotech,负责Novotech的人力资源运营工作,职责包括公司战略、组织发展、薪酬奖励以及工作场所健康和安全等。Angela充满热忱,为实现Novotech的愿景——成为亚太地区领先的CRO而努力。